Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC)

Klineova, S., Harel, A., Straus Farber, R., DeAngelis, T., Zhang, Y., Hentz, R., Leung, T. M., Fong, K., Smith, T., Blanck, R., & Zhovtis-Ryerson, L. (2021). Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC). Multiple Sclerosis and Related Disorders, 55, 103153. https://doi.org/10.1016/j.msard.2021.103153
Authors:
Sylvia Klineova
Asaff Harel
Rebecca Straus Farber
Tracy DeAngelis
Yinan Zhang
Roland Hentz
Tung Ming Leung
Kathryn Fong
Tyler Smith
Richard Blanck
Lana Zhovtis-Ryerson
Affiliated Authors:
Rebecca Straus Farber
Kathryn Fong
Columbia Affiliation:
Author Keywords:
anti-cd20 therapy
antibody
covid-19
multiple sclerosis
elink
Publication Type:
Article
Unique ID:
10.1016/j.msard.2021.103153
PMID:
34392059
DOI:
10.1016/j.msard.2021.103153
Journal:
Multiple Sclerosis and Related Disorders
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: